Internal Medicine, Endocrinology, Diabetes, & Metabolism · Cincinnati, OH
NPI
1902093081
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4760 E Galbraith Rd, Suite 212
Cincinnati, OH, 45236
Phone (513) 686-2663
Groups this clinician bills Medicare through
Medicare paid, 2024
$162K
6,245 services
Medicare patients, 2024
376
Average age 72
Drug cost, 2024
$3.1M
7,643 prescriptions
Company payments, 2025
$120
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Omar Akhtar was code J0897 (injection, denosumab, 1 mg), 4,620 times for 45 patients. In total Omar Akhtar billed 6,245 services in 13 codes, and Medicare paid $162K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-08-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 4,620 | 45 | $20.21 | $93K |
| 99214 Office E&M - Established | Office | 566 | 288 | $84.36 | $48K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 414 | 288 | $12.13 | $5,022 |
| 83036 Blood Count | Office | 254 | 147 | $9.19 | $2,334 |
| 95251 Test - Miscellaneous | Office | 198 | 95 | $24.10 | $4,771 |
| 96372 Injection Administration | Office | 76 | 45 | $8.99 | $683 |
| 99213 Office E&M - Established | Office | 63 | 59 | $53.71 | $3,384 |
| 99204 Office E&M - New | Office | 33 | 33 | $103.57 | $3,418 |
| 99212 Office E&M - Established | Office | 16 | 16 | $39.11 | $626 |
By year: 2022 $157K for 6,635 services; 2023 $149K for 5,914 services; 2024 $162K for 6,245 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 254 | 147 | $9.19 | $2,334 |
Medicare prescription drug claims, 2024
In 2024, the drug Omar Akhtar prescribed most often to Medicare patients was Lantus Solostar (Insulin Glargine,hum.Rec.Anlog), with 634 prescriptions and refills. In total Omar Akhtar wrote 7,643 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 634 | 1,095 | 145 | $100K |
| Levothyroxine Sodium Generic | 554 | 1,432 | 142 | $5,020 |
| Ozempic Semaglutide | 321 | 472 | 69 | $430K |
| Trulicity Dulaglutide | 314 | 386 | 61 | $373K |
| Mounjaro Tirzepatide | 312 | 375 | 58 | $394K |
| Metformin Hcl Generic | 289 | 695 | 72 | $1,819 |
| Alendronate Sodium Generic | 231 | 462 | 55 | $1,159 |
| Jardiance Empagliflozin | 226 | 486 | 58 | $279K |
| Synthroid Levothyroxine Sodium | 219 | 463 | 48 | $17K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 211 | 350 | 49 | $89K |
| Novolog Flexpen Insulin Aspart | 200 | 360 | 67 | $61K |
| Metformin Hcl Er Metformin Hcl | 185 | 461 | 49 | $2,264 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 171 | 291 | 41 | $14K |
| Atorvastatin Calcium Generic | 167 | 443 | 51 | $1,249 |
| Glipizide Er Glipizide | 163 | 377 | 41 | $1,435 |
Brand drugs: 4,321 claims; generic drugs: 2,548 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Omar Akhtar $120 ($120 in general payments such as food, travel and fees) from 3 companies. The largest payer was Medtronic, Inc. with $55.8.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.